KOSUNI KOREA
Korean News in English

Business

3235 articles

Samsung and SK Hynix: Complete Guide to Returning Gains After Market Decline
Business

Samsung and SK Hynix: Complete Guide to Returning Gains After Market Decline

This guide explains the conditions and application process for investors to reclaim gains after Samsung Electronics and SK Hynix's stock price decline due to foreign investor selling pressure in August 2026.
Oct 6, 2026
Understanding the 'Samsung-Naver' Stock Volatility: Clarifying Misconceptions and Policy Facts
Business

Understanding the 'Samsung-Naver' Stock Volatility: Clarifying Misconceptions and Policy Facts

This article clarifies misconceptions about the recent volatility in Samsun-Naver (Samsung Electronics and Naver) stock, analyzing market factors including foreign investor selling pressure and misinformation about memory prices.
Oct 6, 2026
SK Hynix's Chongqing Plant Relocation Plan: What's the Status?
Business

SK Hynix's Chongqing Plant Relocation Plan: What's the Status?

SK Hynix is reportedly considering selling its NAND flash packaging plant in Chongqing, China, but has confirmed no final decision has been made. The potential move is part of broader strategic adjustments amid U.S. regulations and intensifying competition in China's semiconductor market.
Oct 6, 2026
Samsung Bioepis' Keytruda Biosimilar: Efficacy and Safety in Focus
Business

Samsung Bioepis' Keytruda Biosimilar: Efficacy and Safety in Focus

Samsung Bioepis has submitted a biosimilar application for Keytruda, the world's top-selling cancer drug, aiming to capitalize on its 2026 patent expiration and compete in the $43 trillion market.
Oct 6, 2026
SK Hynix Chongqing Plant's Technical Features and Production Process
Business

SK Hynix Chongqing Plant's Technical Features and Production Process

SK Hynix's Chongqing plant, responsible for post-processing of NAND flash memory in China, is under review for potential sale amid U.S. regulations and Chinese competition.
Oct 6, 2026
Is Samsung Bioepis' Keytruda Biosimilar Effective for Cancer Treatment?
Business

Is Samsung Bioepis' Keytruda Biosimilar Effective for Cancer Treatment?

Samsung Bioepis has demonstrated clinical equivalence of its biosimilar SB27 to Keytruda in a Phase 3 trial, positioning it as a potential market leader in the growing biosimilar oncology sector.
Oct 6, 2026
Why Hanwha KAI Stake Acquisition Matters: Strategic Analysis
Business

Why Hanwha KAI Stake Acquisition Matters: Strategic Analysis

Hanwha Group's acquisition of 15.89% stake in Korea Aerospace Industries (KAI) marks a strategic move toward becoming a comprehensive defense and aerospace conglomerate, aiming to enhance synergy and respond to privatization discussions.
Oct 6, 2026
Hanwha KAI Equity Acquisition and Evolving Corporate Partnerships
Business

Hanwha KAI Equity Acquisition and Evolving Corporate Partnerships

Hanwha Group has secured a 15.89% stake in Korea Aerospace Industries (KAI), positioning itself as the second-largest shareholder, with plans to accelerate strategic growth in aerospace and defense sectors.
Oct 6, 2026
Understanding the Korea-Mexico Dialogue Channel: Meaning and Practical Use
Business

Understanding the Korea-Mexico Dialogue Channel: Meaning and Practical Use

The Korea-Mexico Dialogue Channel, launched by President Yoon Suk Yeol during a September 2026 visit to Mexico, aims to strengthen oil and critical mineral supply chains between the two nations.
Oct 6, 2026
Samsung Electronics' Dividend Surge Reaches New High Amid Strong Performance and Market Trends
Business

Samsung Electronics' Dividend Surge Reaches New High Amid Strong Performance and Market Trends

Samsung Electronics has reported record-breaking revenue and profits, leading to a significant dividend increase that correlates with rising stock prices. The company's strategic focus on AI memory technology is driving market confidence.
Oct 6, 2026
Expected Stock Fluctuations Following Hanwha KAI Equity Acquisition
Business

Expected Stock Fluctuations Following Hanwha KAI Equity Acquisition

Hanwha Group has re-entered KAI investment after seven years, increasing its stake to 15.89% and becoming the second-largest shareholder. The acquisition is subject to antitrust review and may boost KAI's stock price due to anticipated synergies in defense and aerospace sectors.
Oct 6, 2026
Samsung Electronics' Dividend Surge: A Financial Analysis
Business

Samsung Electronics' Dividend Surge: A Financial Analysis

Samsung Electronics has reported record-breaking annual revenue in 2025, leading to a significant increase in dividends. The company's strong memory sector performance and expanded shareholder return policies are driving this trend.
Oct 6, 2026